DDI Drug Name |
DDI Drug ID |
Severity |
Mechanism |
Comorbidity |
REF |
Midostaurin |
DMI6E0R
|
Moderate |
Increased metabolism of Amobarbital caused by Midostaurin mediated induction of CYP450 enzyme. |
Acute myeloid leukaemia [2A60]
|
[9] |
Gilteritinib |
DMTI0ZO
|
Moderate |
Increased metabolism of Amobarbital caused by Gilteritinib mediated induction of CYP450 enzyme. |
Acute myeloid leukaemia [2A60]
|
[10] |
Oliceridine |
DM6MDCF
|
Major |
Additive CNS depression effects by the combination of Amobarbital and Oliceridine. |
Acute pain [MG31]
|
[11] |
Ivabradine |
DM0L594
|
Moderate |
Increased metabolism of Amobarbital caused by Ivabradine mediated induction of CYP450 enzyme. |
Angina pectoris [BA40]
|
[12] |
Dronedarone |
DMA8FS5
|
Moderate |
Increased metabolism of Amobarbital caused by Dronedarone mediated induction of CYP450 enzyme. |
Angina pectoris [BA40]
|
[13] |
Bedaquiline |
DM3906J
|
Moderate |
Increased metabolism of Amobarbital caused by Bedaquiline mediated induction of CYP450 enzyme. |
Antimicrobial drug resistance [MG50-MG52]
|
[14] |
Ixabepilone |
DM2OZ3G
|
Moderate |
Increased metabolism of Amobarbital caused by Ixabepilone mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[15] |
LY2835219 |
DM93VBZ
|
Moderate |
Increased metabolism of Amobarbital caused by LY2835219 mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[16] |
Esterified estrogens |
DM9KZDO
|
Moderate |
Increased metabolism of Amobarbital caused by Esterified estrogens mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[17] |
Tucatinib |
DMBESUA
|
Moderate |
Increased metabolism of Amobarbital caused by Tucatinib mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[18] |
Palbociclib |
DMD7L94
|
Moderate |
Increased metabolism of Amobarbital caused by Palbociclib mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[19] |
Alpelisib |
DMEXMYK
|
Moderate |
Increased metabolism of Amobarbital caused by Alpelisib mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[20] |
Quinestrol |
DMJ6H1Z
|
Moderate |
Increased metabolism of Amobarbital caused by Quinestrol mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[21] |
Cabazitaxel |
DMPAZHC
|
Moderate |
Increased metabolism of Amobarbital caused by Cabazitaxel mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[22] |
Bosutinib |
DMTI8YE
|
Moderate |
Increased metabolism of Amobarbital caused by Bosutinib mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[23] |
Macitentan |
DMP79A1
|
Moderate |
Increased metabolism of Amobarbital caused by Macitentan mediated induction of CYP450 enzyme. |
Cardiovascular disease [BA00-BE2Z]
|
[24] |
Doxercalciferol |
DM6FG1P
|
Moderate |
Increased metabolism of Amobarbital caused by Doxercalciferol mediated induction of CYP450 enzyme. |
Chronic kidney disease [GB61]
|
[25] |
PF-04449913 |
DMSB068
|
Moderate |
Increased metabolism of Amobarbital caused by PF-04449913 mediated induction of CYP450 enzyme. |
Chronic myelomonocytic leukaemia [2A40]
|
[26] |
Dihydrocodeine |
DMB0FWL
|
Major |
Additive CNS depression effects by the combination of Amobarbital and Dihydrocodeine. |
Chronic pain [MG30]
|
[27] |
Drospirenone |
DM1A9W3
|
Moderate |
Increased metabolism of Amobarbital caused by Drospirenone mediated induction of CYP450 enzyme. |
Contraceptive management [QA21]
|
[17] |
Levonorgestrel |
DM1DP7T
|
Moderate |
Increased metabolism of Amobarbital caused by Levonorgestrel mediated induction of CYP450 enzyme. |
Contraceptive management [QA21]
|
[21] |
Ulipristal |
DMBNI20
|
Moderate |
Increased metabolism of Amobarbital caused by Ulipristal mediated induction of CYP450 enzyme. |
Contraceptive management [QA21]
|
[12] |
Osilodrostat |
DMIJC9X
|
Moderate |
Increased metabolism of Amobarbital caused by Osilodrostat mediated induction of CYP450 enzyme. |
Cushing syndrome [5A70]
|
[18] |
Ivacaftor |
DMZC1HS
|
Moderate |
Increased metabolism of Amobarbital caused by Ivacaftor mediated induction of CYP450 enzyme. |
Cystic fibrosis [CA25]
|
[28] |
Rivaroxaban |
DMQMBZ1
|
Moderate |
Increased metabolism of Amobarbital caused by Rivaroxaban mediated induction of CYP450 enzyme. |
Deep vein thrombosis [BD71]
|
[29] |
Vilazodone |
DM4LECQ
|
Moderate |
Increased metabolism of Amobarbital caused by Vilazodone mediated induction of CYP450 enzyme. |
Depression [6A70-6A7Z]
|
[30] |
Vortioxetine |
DM6F1PU
|
Moderate |
Increased metabolism of Amobarbital caused by Vortioxetine mediated induction of CYP450 enzyme. |
Depression [6A70-6A7Z]
|
[31] |
Esketamine |
DMVU687
|
Moderate |
Additive CNS depression effects by the combination of Amobarbital and Esketamine. |
Depression [6A70-6A7Z]
|
[19] |
[3H]estrone-3-sulphate |
DMGPF0N
|
Moderate |
Increased metabolism of Amobarbital caused by [3H]estrone-3-sulphate mediated induction of CYP450 enzyme. |
Discovery agent [N.A.]
|
[21] |
Stiripentol |
DMMSDOY
|
Moderate |
Increased metabolism of Amobarbital caused by Stiripentol mediated induction of CYP450 enzyme. |
Epilepsy/seizure [8A61-8A6Z]
|
[12] |
Bay 80-6946 |
DMLOS5R
|
Moderate |
Increased metabolism of Amobarbital caused by Bay 80-6946 mediated induction of CYP450 enzyme. |
Follicular lymphoma [2A80]
|
[32] |
Tazemetostat |
DMWP1BH
|
Moderate |
Increased metabolism of Amobarbital caused by Tazemetostat mediated induction of CYP450 enzyme. |
Follicular lymphoma [2A80]
|
[33] |
Solifenacin |
DMG592Q
|
Moderate |
Increased metabolism of Amobarbital caused by Solifenacin mediated induction of CYP450 enzyme. |
Functional bladder disorder [GC50]
|
[34] |
Mirabegron |
DMS1GYT
|
Minor |
Increased metabolism of Amobarbital caused by Mirabegron mediated induction of CYP450 enzyme. |
Functional bladder disorder [GC50]
|
[35] |
Ripretinib |
DM958QB
|
Moderate |
Increased metabolism of Amobarbital caused by Ripretinib mediated induction of CYP450 enzyme. |
Gastrointestinal stromal tumour [2B5B]
|
[19] |
Avapritinib |
DMK2GZX
|
Moderate |
Increased metabolism of Amobarbital caused by Avapritinib mediated induction of CYP450 enzyme. |
Gastrointestinal stromal tumour [2B5B]
|
[12] |
Digitoxin |
DMWVIGP
|
Moderate |
Increased metabolism of Amobarbital caused by Digitoxin mediated induction of CYP450 enzyme. |
Heart failure [BD10-BD1Z]
|
[36] |
Boceprevir |
DMBSHMF
|
Moderate |
Increased metabolism of Amobarbital caused by Boceprevir mediated induction of CYP450 enzyme. |
Hepatitis virus infection [1E50-1E51]
|
[37] |
Telaprevir |
DMMRV29
|
Moderate |
Increased metabolism of Amobarbital caused by Telaprevir mediated induction of CYP450 enzyme. |
Hepatitis virus infection [1E50-1E51]
|
[37] |
MK-1439 |
DM215WE
|
Moderate |
Increased metabolism of Amobarbital caused by MK-1439 mediated induction of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[38] |
Fostemsavir |
DM50ILT
|
Minor |
Increased metabolism of Amobarbital caused by Fostemsavir mediated induction of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[18] |
Etravirine |
DMGV8QU
|
Moderate |
Increased metabolism of Amobarbital caused by Etravirine mediated induction of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[39] |
Rilpivirine |
DMJ0QOW
|
Moderate |
Increased metabolism of Amobarbital caused by Rilpivirine mediated induction of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[19] |
Maraviroc |
DMTL94F
|
Moderate |
Increased metabolism of Amobarbital caused by Maraviroc mediated induction of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[19] |
Penbutolol |
DM4ES8F
|
Moderate |
Increased metabolism of Amobarbital caused by Penbutolol mediated induction of CYP450 enzyme. |
Hypertension [BA00-BA04]
|
[40] |
Nebivolol |
DM7F1PA
|
Moderate |
Increased metabolism of Amobarbital caused by Nebivolol mediated induction of CYP450 enzyme. |
Hypertension [BA00-BA04]
|
[41] |
Levamlodipine |
DM92S6N
|
Moderate |
Increased metabolism of Amobarbital caused by Levamlodipine mediated induction of CYP450 enzyme. |
Hypertension [BA00-BA04]
|
[42] |
Tolvaptan |
DMIWFRL
|
Moderate |
Increased metabolism of Amobarbital caused by Tolvaptan mediated induction of CYP450 enzyme. |
Hypo-osmolality/hyponatraemia [5C72]
|
[12] |
Lesinurad |
DMUR64T
|
Moderate |
Increased metabolism of Amobarbital caused by Lesinurad mediated induction of CYP450 enzyme. |
Inborn purine/pyrimidine/nucleotide metabolism error [5C55]
|
[43] |
Naloxegol |
DML0B41
|
Moderate |
Increased metabolism of Amobarbital caused by Naloxegol mediated induction of CYP450 enzyme. |
Large intestine motility disorder [DB32]
|
[44] |
Pemigatinib |
DM819JF
|
Moderate |
Increased metabolism of Amobarbital caused by Pemigatinib mediated induction of CYP450 enzyme. |
Liver cancer [2C12]
|
[45] |
Crizotinib |
DM4F29C
|
Moderate |
Increased metabolism of Amobarbital caused by Crizotinib mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[46] |
Brigatinib |
DM7W94S
|
Moderate |
Increased metabolism of Amobarbital caused by Brigatinib mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[19] |
Ceritinib |
DMB920Z
|
Moderate |
Increased metabolism of Amobarbital caused by Ceritinib mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[47] |
Lurbinectedin |
DMEFRTZ
|
Moderate |
Increased metabolism of Amobarbital caused by Lurbinectedin mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[48] |
Osimertinib |
DMRJLAT
|
Moderate |
Increased metabolism of Amobarbital caused by Osimertinib mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[49] |
Capmatinib |
DMYCXKL
|
Moderate |
Increased metabolism of Amobarbital caused by Capmatinib mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[50] |
Selpercatinib |
DMZR15V
|
Moderate |
Increased metabolism of Amobarbital caused by Selpercatinib mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[18] |
Artemether |
DM48QOT
|
Moderate |
Increased metabolism of Amobarbital caused by Artemether mediated induction of CYP450 enzyme. |
Malaria [1F40-1F45]
|
[19] |
Idelalisib |
DM602WT
|
Moderate |
Increased metabolism of Amobarbital caused by Idelalisib mediated induction of CYP450 enzyme. |
Mature B-cell leukaemia [2A82]
|
[51] |
GDC-0199 |
DMH0QKA
|
Moderate |
Increased metabolism of Amobarbital caused by GDC-0199 mediated induction of CYP450 enzyme. |
Mature B-cell leukaemia [2A82]
|
[52] |
IPI-145 |
DMWA24P
|
Moderate |
Increased metabolism of Amobarbital caused by IPI-145 mediated induction of CYP450 enzyme. |
Mature B-cell leukaemia [2A82]
|
[53] |
Acalabrutinib |
DM7GCVW
|
Moderate |
Increased metabolism of Amobarbital caused by Acalabrutinib mediated induction of CYP450 enzyme. |
Mature B-cell lymphoma [2A85]
|
[54] |
Ibrutinib |
DMHZCPO
|
Moderate |
Increased metabolism of Amobarbital caused by Ibrutinib mediated induction of CYP450 enzyme. |
Mature B-cell lymphoma [2A85]
|
[55] |
Ponatinib |
DMYGJQO
|
Moderate |
Increased metabolism of Amobarbital caused by Ponatinib mediated induction of CYP450 enzyme. |
Mature B-cell lymphoma [2A85]
|
[19] |
Vemurafenib |
DM62UG5
|
Moderate |
Increased metabolism of Amobarbital caused by Vemurafenib mediated induction of CYP450 enzyme. |
Melanoma [2C30]
|
[56] |
Selumetinib |
DMC7W6R
|
Moderate |
Increased metabolism of Amobarbital caused by Selumetinib mediated induction of CYP450 enzyme. |
Melanoma [2C30]
|
[57] |
LGX818 |
DMNQXV8
|
Moderate |
Increased metabolism of Amobarbital caused by LGX818 mediated induction of CYP450 enzyme. |
Melanoma [2C30]
|
[58] |
Allopregnanolone |
DMNLHAC
|
Moderate |
Additive CNS depression effects by the combination of Amobarbital and Allopregnanolone. |
Mental/behavioural/neurodevelopmental disorder [6E20-6E8Z]
|
[59] |
Ubrogepant |
DM749I3
|
Moderate |
Increased metabolism of Amobarbital caused by Ubrogepant mediated induction of CYP450 enzyme. |
Migraine [8A80]
|
[60] |
Lasmiditan |
DMXLVDT
|
Moderate |
Additive CNS depression effects by the combination of Amobarbital and Lasmiditan. |
Migraine [8A80]
|
[61] |
Flibanserin |
DM70DTN
|
Moderate |
Additive CNS depression effects by the combination of Amobarbital and Flibanserin. |
Mood disorder [6A60-6E23]
|
[62] |
Panobinostat |
DM58WKG
|
Moderate |
Increased metabolism of Amobarbital caused by Panobinostat mediated induction of CYP450 enzyme. |
Multiple myeloma [2A83]
|
[63] |
Nilotinib |
DM7HXWT
|
Moderate |
Increased metabolism of Amobarbital caused by Nilotinib mediated induction of CYP450 enzyme. |
Myeloproliferative neoplasm [2A20]
|
[64] |
Ruxolitinib |
DM7Q98D
|
Moderate |
Increased metabolism of Amobarbital caused by Ruxolitinib mediated induction of CYP450 enzyme. |
Myeloproliferative neoplasm [2A20]
|
[65] |
Rolapitant |
DM8XP26
|
Moderate |
Increased metabolism of Amobarbital caused by Rolapitant mediated induction of CYP450 enzyme. |
Nausea/vomiting [MD90]
|
[66] |
E-2007 |
DMJDYNQ
|
Moderate |
Increased metabolism of Amobarbital caused by E-2007 mediated induction of CYP450 enzyme. |
Neuropathy [8C0Z]
|
[12] |
Entrectinib |
DMMPTLH
|
Moderate |
Increased metabolism of Amobarbital caused by Entrectinib mediated induction of CYP450 enzyme. |
Non-small cell lung cancer [2C25]
|
[12] |
Olaparib |
DM8QB1D
|
Moderate |
Increased metabolism of Amobarbital caused by Olaparib mediated induction of CYP450 enzyme. |
Ovarian cancer [2C73]
|
[19] |
Pimavanserin |
DMR7IVC
|
Moderate |
Increased metabolism of Amobarbital caused by Pimavanserin mediated induction of CYP450 enzyme. |
Parkinsonism [8A00]
|
[67] |
Macimorelin |
DMQYJIR
|
Moderate |
Increased metabolism of Amobarbital caused by Macimorelin mediated induction of CYP450 enzyme. |
Pituitary gland disorder [5A60-5A61]
|
[68] |
Lefamulin |
DME6G97
|
Moderate |
Increased metabolism of Amobarbital caused by Lefamulin mediated induction of CYP450 enzyme. |
Pneumonia [CA40]
|
[69] |
Lonafarnib |
DMGM2Z6
|
Moderate |
Increased metabolism of Amobarbital caused by Lonafarnib mediated induction of CYP450 enzyme. |
Premature ageing appearance [LD2B]
|
[70] |
Enzalutamide |
DMGL19D
|
Moderate |
Increased metabolism of Amobarbital caused by Enzalutamide mediated induction of CYP450 enzyme. |
Prostate cancer [2C82]
|
[71] |
Darolutamide |
DMV7YFT
|
Moderate |
Increased metabolism of Amobarbital caused by Darolutamide mediated induction of CYP450 enzyme. |
Prostate cancer [2C82]
|
[72] |
Apremilast |
DMTWS9E
|
Moderate |
Increased metabolism of Amobarbital caused by Apremilast mediated induction of CYP450 enzyme. |
Psoriasis [EA90]
|
[73] |
Riociguat |
DMXBLMP
|
Moderate |
Increased metabolism of Amobarbital caused by Riociguat mediated induction of CYP450 enzyme. |
Pulmonary hypertension [BB01]
|
[74] |
Everolimus |
DM8X2EH
|
Moderate |
Increased metabolism of Amobarbital caused by Everolimus mediated induction of CYP450 enzyme. |
Renal cell carcinoma [2C90]
|
[19] |
Axitinib |
DMGVH6N
|
Moderate |
Increased metabolism of Amobarbital caused by Axitinib mediated induction of CYP450 enzyme. |
Renal cell carcinoma [2C90]
|
[75] |
Temsirolimus |
DMS104F
|
Moderate |
Increased metabolism of Amobarbital caused by Temsirolimus mediated induction of CYP450 enzyme. |
Renal cell carcinoma [2C90]
|
[19] |
Tofacitinib |
DMBS370
|
Moderate |
Increased metabolism of Amobarbital caused by Tofacitinib mediated induction of CYP450 enzyme. |
Rheumatoid arthritis [FA20]
|
[19] |
Avanafil |
DM75CXN
|
Moderate |
Increased metabolism of Amobarbital caused by Avanafil mediated induction of CYP450 enzyme. |
Sexual dysfunction [HA00-HA01]
|
[76] |
LDE225 |
DMM9F25
|
Moderate |
Increased metabolism of Amobarbital caused by LDE225 mediated induction of CYP450 enzyme. |
Skin cancer [2C30-2C37]
|
[77] |
Larotrectinib |
DM26CQR
|
Moderate |
Increased metabolism of Amobarbital caused by Larotrectinib mediated induction of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[19] |
Trabectedin |
DMG3Y89
|
Moderate |
Increased metabolism of Amobarbital caused by Trabectedin mediated induction of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[12] |
Armodafinil |
DMGB035
|
Moderate |
Increased metabolism of Amobarbital caused by Armodafinil mediated induction of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[78] |
LEE011 |
DMMX75K
|
Moderate |
Increased metabolism of Amobarbital caused by LEE011 mediated induction of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[19] |
Fostamatinib |
DM6AUHV
|
Moderate |
Increased metabolism of Amobarbital caused by Fostamatinib mediated induction of CYP450 enzyme. |
Thrombocytopenia [3B64]
|
[18] |
Apixaban |
DM89JLN
|
Moderate |
Increased metabolism of Amobarbital caused by Apixaban mediated induction of CYP450 enzyme. |
Thrombosis [DB61-GB90]
|
[79] |
Brilinta |
DMBR01X
|
Moderate |
Increased metabolism of Amobarbital caused by Brilinta mediated induction of CYP450 enzyme. |
Thrombosis [DB61-GB90]
|
[80] |
Canagliflozin |
DMFRM1I
|
Moderate |
Increased metabolism of Amobarbital caused by Canagliflozin mediated induction of UGT. |
Type 2 diabetes mellitus [5A11]
|
[19] |
Saxagliptin |
DMGXENV
|
Moderate |
Increased metabolism of Amobarbital caused by Saxagliptin mediated induction of CYP450 enzyme. |
Type 2 diabetes mellitus [5A11]
|
[81] |
Linagliptin |
DMWFJTR
|
Moderate |
Increased metabolism of Amobarbital caused by Linagliptin mediated induction of CYP450 enzyme. |
Type 2 diabetes mellitus [5A11]
|
[82] |
Elagolix |
DMB2C0E
|
Moderate |
Increased metabolism of Amobarbital caused by Elagolix mediated induction of CYP450 enzyme. |
Uterine fibroid [2E86]
|
[83] |
----------- |
|
|
|
|
|